South Korea

Lotte Biologics Unveils Songdo Bio Plant Development Plan at JPM Healthcare Conference 2024

Richard Lee, CEO of LOTTE BIOLOGICS, delivers a keynote speech at the JPM Healthcare Conference for the second consecutive year Unveils company's b...

 January 11, 2024 | News

GC Cell Initiates Phase 1 Trials for AB-201 Cancer Treatment with Lunit AI Platform

 GC Cell, a fully integrated cell therapy pioneer, is proud to announce the approval from both the Australian Human Research Ethics Committee (HREC) a...

 January 09, 2024 | News

Health On Cloud Goes Global with Metaverse Medical Platform

This expansion is scheduled to launch in Kazakhstan, Colombia, and several other Latin American countries in 2024, marking a strategic move that ...

 January 02, 2024 | News

TiumBio Raises KRW 38.5B for Upcoming Clinical Data

The proceeds will fund its robust clinical programs and bolster TiumBio's financial position. Data read-outs from a Phase 2 trial of merigolix...

 January 01, 2024 | News

Dx&Vx Partners with LG CNS to Develop Bio-Health Data Platform in South Korea

Dx&Vx recently announced on the 18th that it has signed a contract with LG CNS to jointly develop a bio-healthcare big data platform utilizing AI ...

 December 21, 2023 | News

GC Biopharma's ALYGLO™ 10% Liquid FDA Approved for Adult Primary Immunodeficiency.

The ALYGLO pivotal phase 3 clinical study followed FDA guidance for the treatment of patients with PI. The clinical trial (NCT02783482) GC5107B was a prosp...

 December 18, 2023 | News

Lunit Secures Acquisition of Volpara: Agreement on Scheme Implementation Established

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its proposal to acquire Volpara Health...

 December 15, 2023 | News

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with tha...

 November 27, 2023 | News

DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...

 November 27, 2023 | News

PharmAbcine Reveals PMC-403 Potential in Idiopathic Systemic Capillary Leak Syndrome Models

The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclini...

 November 23, 2023 | News

SK Bioscience and Hilleman Labs Collaborate on Next-Gen Ebola Vaccine

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entere...

 November 22, 2023 | News

Lunit's AI Chest Screening to Deploy in Five Saudi Hospitals

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced an expansion of its services in the&nb...

 November 17, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

 Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,  announced the successful completion ...

 November 16, 2023 | News

Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market

 Lunit  a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,  announced that it has received U.S. Food and Dr...

 November 15, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close